These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10394465)

  • 1. [Visceral leishmaniasis: a new oral treatment?].
    Minodier P; Nicaise C; Gire C; Garnier JM
    Arch Pediatr; 1999 Jun; 6(6):687-8. PubMed ID: 10394465
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of visceral leishmaniasis: efficacy and limits of miltefosine].
    Gangneux JP; Marty P
    Sante; 2001; 11(4):257-8. PubMed ID: 11861203
    [No Abstract]   [Full Text] [Related]  

  • 3. Miltefosine--the long-awaited therapy for visceral leishmaniasis?
    Herwaldt BL
    N Engl J Med; 1999 Dec; 341(24):1840-2. PubMed ID: 10588972
    [No Abstract]   [Full Text] [Related]  

  • 4. [Leishmaniasis--oral treatment with hexadecylphosphocholine].
    Bommer W; Eibl HJ; Engel KR; Kuhlencord A; Sindermann H; Sundar S; Zappel H
    Wien Klin Wochenschr; 2004; 116 Suppl 4():24-9. PubMed ID: 15683039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An oral drug for leishmaniasis.
    Jacobs S
    N Engl J Med; 2002 Nov; 347(22):1737-8. PubMed ID: 12456848
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral miltefosine treatment in children with visceral leishmaniasis: a brief review.
    Palumbo E
    Braz J Infect Dis; 2008 Feb; 12(1):2-4. PubMed ID: 18553005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine: an oral drug for visceral leishmaniasis.
    Prasad R; Kumar R; Jaiswal BP; Singh UK
    Indian J Pediatr; 2004 Feb; 71(2):143-4. PubMed ID: 15053378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapy for visceral leishmaniasis.
    Wkly Epidemiol Rec; 2002 Jun; 77(25):210-2. PubMed ID: 12132132
    [No Abstract]   [Full Text] [Related]  

  • 9. Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis.
    Fischer C; Voss A; Engel J
    Med Microbiol Immunol; 2001 Nov; 190(1-2):85-7. PubMed ID: 11770118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miltefosine in visceral leishmaniasis.
    Olliaro PL; Ridley RG; Engel J; Sindermann H; Bryceson AD
    Lancet Infect Dis; 2003 Feb; 3(2):70. PubMed ID: 12560189
    [No Abstract]   [Full Text] [Related]  

  • 11. Miltefosine for visceral leishmaniasis.
    Sherwood JA
    N Engl J Med; 2000 Mar; 342(12):895. PubMed ID: 10733377
    [No Abstract]   [Full Text] [Related]  

  • 12. Miltefosine for visceral leishmaniasis.
    Eibl H
    N Engl J Med; 2000 Mar; 342(12):894-5. PubMed ID: 10733376
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of visceral leishmaniasis: options and choice.
    Bhattacharya SK; Dash AP
    Lancet Infect Dis; 2016 Feb; 16(2):142-3. PubMed ID: 26867454
    [No Abstract]   [Full Text] [Related]  

  • 14. Miltefosine for Indian visceral leishmaniasis.
    Roca B
    N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12608397
    [No Abstract]   [Full Text] [Related]  

  • 15. Breakthrough in the management of visceral leishmaniasis.
    Thakur BB
    J Assoc Physicians India; 2003 Jul; 51():649-51. PubMed ID: 14621030
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy for visceral leishmaniasis.
    van Griensven J; Boelaert M
    Lancet; 2011 Feb; 377(9764):443-4. PubMed ID: 21255829
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of leishmaniasis with miltefosine: 2008 status.
    Berman JJ
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miltefosine for Indian visceral leishmaniasis.
    Agarwal PK
    N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12606744
    [No Abstract]   [Full Text] [Related]  

  • 19. Miltefosine presents new hope for leishmaniasis patients.
    Paterson R
    Lancet Infect Dis; 2002 Aug; 2(8):452. PubMed ID: 12150830
    [No Abstract]   [Full Text] [Related]  

  • 20. Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunction.
    Kumar N; Pandey K; Das VN; Sinha PK; Topno RK; Verma N; Lal CS; Das P; Bhattacharya SK
    Ann Trop Med Parasitol; 2007 Oct; 101(7):649-51. PubMed ID: 17877883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.